IPO Listed — 04 Feb 2026
Listing Price: ₹191
Accretion Nutraveda SME IPO GMP History | Listing Price ₹191 & Kostak Rate
Accretion Nutraveda SME IPO has been listed on February 4, 2026 at a listing price of ₹191, against the issue price of ₹129 — a gain of ₹62 (+48.06%). The GMP peaked at ₹65 on 4 February 2026 and reached a low of ₹0 on 30 January 2026. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Accretion Nutraveda SME IPO raised ₹24.77 Cr. Cr. through its IPO at a price band of ₹122 to ₹129 per share, with a lot size of 1000 shares. The IPO was open for subscription from 28 Jan 2026 to 30 Jan 2026.
GMP Trend Chart
Day-wise GMP Trend
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 04 Feb 2026 | ₹ 65 | 50% | ₹ 0 | ₹ 0 | |
| 03 Feb 2026 | ₹ 17 | 13% | ₹ 0 | ₹ 0 | |
| 02 Feb 2026 | ₹ 6 | 5% | ₹ 0 | ₹ 0 | |
| 01 Feb 2026 | ₹ 6 | 5% | ₹ 0 | ₹ 0 | |
| 31 Jan 2026 | ₹ 6 | 5% | ₹ 0 | ₹ 0 | |
| 30 Jan 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 29 Jan 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 28 Jan 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 27 Jan 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 26 Jan 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 23 Jan 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 22 Jan 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 21 Jan 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 20 Jan 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 |
Accretion Nutraveda SME IPO Dates
| Event | Date |
|---|---|
| Open Date | 28 Jan, 2026 |
| Close Date | 30 Jan, 2026 |
| Allotment Date | 02 Feb, 2026 |
| Refund Date | 03 Feb, 2026 |
| Credit to Demat | 03 Feb, 2026 |
| Listing Date | 04 Feb, 2026 |
Accretion Nutraveda SME IPO Actual Listing Price
| Basis | Value |
|---|---|
| Issue Price | ₹129 |
| GMP-Based Estimate (Pre-Listing) | ₹194 (+50.4%) |
| Actual Listing Price | ₹191 (+48.06%) |
| Listing Gain / Loss | +₹62 per share |
| Listing Date | 04 Feb, 2026 |
Is Accretion Nutraveda SME IPO GMP Reliable?
Grey market premium for Accretion Nutraveda SME IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- Cross-check before acting: Review the Accretion Nutraveda SME IPO full review for a fundamentals-based assessment before making any grey market trades.
Accretion Nutraveda SME IPO IPO Kostak Rate Explained
The Kostak rate for Accretion Nutraveda SME IPO was not active during the subscription period, as no grey market premium was established. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not active for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Accretion Nutraveda SME IPO
The company operates as a Contract Development and Manufacturing Organization (CDMO), serving both domestic and international markets such as Sri Lanka, Singapore, and the USA. Its products combine classical Ayurvedic principles with modern nutraceutical science to address areas like liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness.
Frequently Asked Questions about Accretion Nutraveda SME IPO
What is the GMP of Accretion Nutraveda SME IPO?
The current Grey Market Premium (GMP) of Accretion Nutraveda SME IPO is ₹ 65.
What is the Kostak Price of Accretion Nutraveda SME IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Accretion Nutraveda SME IPO is : Retail: ₹ 0, SHNI: ₹ 0, BHNI: ₹ 0.
What is the Subject to Sauda Price of Accretion Nutraveda SME IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is : Retail: ₹ 0, SHNI: ₹ 0, BHNI: ₹ 0.
What was the actual listing price of Accretion Nutraveda SME IPO?
Accretion Nutraveda SME IPO listed on February 4, 2026 at ₹191, against the issue price of ₹129 — a gain of +48.06%.
How did the GMP of Accretion Nutraveda SME IPO trend before listing?
The GMP of Accretion Nutraveda SME IPO was rising in its final days before listing. The GMP peaked at ₹65 on 4 February 2026. View the day-wise table above for the complete GMP history.
Explore Accretion Nutraveda SME IPO Further
For a complete picture before making your investment decision, explore these resources:
Discussion 0
No comments yet
Be the first to share your thoughts!